AIMS: To test the hypothesis that echocardiographic tissue Doppler imaging (TDI) reveals reduced myocardial function in hypertension, diabetes, and ischaemic heart disease (IHD) in the general population. METHODS AND RESULTS: Within a large, community-based population study, cardiac function was evaluated in 1036 participants by both conventional echocardiography and colour TDI. Peak systolic (s') and early diastolic (e') velocities, longitudinal displacement (LD), and the ratio of mitral inflow E-wave to e' (E/e') were measured. TDI revealed significantly impaired parameters of systolic and diastolic cardiac function in hypertension [n = 345; LD 10.1 (+/-standard deviation, SD 2.0 mm), P < 0.001; E/e' 12.4 (x/SD 1.4), P < 0.001], diabetes [n = 65; LD 9.8 (+/-SD 2.2 mm), P < 0.001; E/e' 12.7 (x/SD 1.5), P < 0.001], and IHD [n = 93; LD 9.4 (+/-SD 2.5 mm), P < 0.001; E/e' 13.0 (x/SD 1.5), P < 0.001] compared with controls [n = 533; LD 11.4 (+/-SD 2.0 mm); E/e' 9.0 (x/SD 1.3)]. This pattern remained significant after adjusting for age, sex, body mass index, heart rate, and the results of conventional echocardiography. CONCLUSION: In the general population, persons with hypertension, diabetes, or IHD have impaired cardiac function by TDI independently of the result of conventional echocardiography.
AIMS: To test the hypothesis that echocardiographic tissue Doppler imaging (TDI) reveals reduced myocardial function in hypertension, diabetes, and ischaemic heart disease (IHD) in the general population. METHODS AND RESULTS: Within a large, community-based population study, cardiac function was evaluated in 1036 participants by both conventional echocardiography and colour TDI. Peak systolic (s') and early diastolic (e') velocities, longitudinal displacement (LD), and the ratio of mitral inflow E-wave to e' (E/e') were measured. TDI revealed significantly impaired parameters of systolic and diastolic cardiac function in hypertension [n = 345; LD 10.1 (+/-standard deviation, SD 2.0 mm), P < 0.001; E/e' 12.4 (x/SD 1.4), P < 0.001], diabetes [n = 65; LD 9.8 (+/-SD 2.2 mm), P < 0.001; E/e' 12.7 (x/SD 1.5), P < 0.001], and IHD [n = 93; LD 9.4 (+/-SD 2.5 mm), P < 0.001; E/e' 13.0 (x/SD 1.5), P < 0.001] compared with controls [n = 533; LD 11.4 (+/-SD 2.0 mm); E/e' 9.0 (x/SD 1.3)]. This pattern remained significant after adjusting for age, sex, body mass index, heart rate, and the results of conventional echocardiography. CONCLUSION: In the general population, persons with hypertension, diabetes, or IHD have impaired cardiac function by TDI independently of the result of conventional echocardiography.
Authors: Joanna Nan Wang; Tor Biering-Sørensen; Peter Godsk Jørgensen; Jan Skov Jensen; Rasmus Mogelvang Journal: Int J Cardiovasc Imaging Date: 2017-01-09 Impact factor: 2.357
Authors: Cesare Russo; Zhezhen Jin; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio Journal: Eur J Heart Fail Date: 2010-03-07 Impact factor: 15.534
Authors: Giora Landesberg; Dan Gilon; Yuval Meroz; Milena Georgieva; Phillip D Levin; Sergey Goodman; Alexander Avidan; Ronen Beeri; Charles Weissman; Allan S Jaffe; Charles L Sprung Journal: Eur Heart J Date: 2011-09-11 Impact factor: 29.983
Authors: Maria Dons; Tor BieringSørensen; Jan Skov Jensen; Thomas Fritz-Hansen; Jan Bech; Martina Chantal de Knegt; Jacob Sivertsen; Flemming Javier Olsen; Rasmus Mogelvang Journal: J Atr Fibrillation Date: 2015-06-30
Authors: Andrew H Tran; Joseph T Flynn; Richard C Becker; Stephen R Daniels; Bonita E Falkner; Michael Ferguson; Coral D Hanevold; Stephen R Hooper; Julie R Ingelfinger; Marc B Lande; Lisa J Martin; Kevin Meyers; Mark Mitsnefes; Bernard Rosner; Joshua A Samuels; Elaine M Urbina Journal: Hypertension Date: 2020-05-04 Impact factor: 10.190
Authors: Kristoffer Grundtvig Skaarup; Mats Christian Højbjerg Lassen; Jacob Louis Marott; Sofie R Biering-Sørensen; Peter Godsk Jørgensen; Merete Appleyard; Jens Berning; Nis Høst; Gorm Jensen; Peter Schnohr; Peter Søgaard; Gunnar Gislason; Rasmus Møgelvang; Tor Biering-Sørensen Journal: Int J Cardiovasc Imaging Date: 2020-06-07 Impact factor: 2.357
Authors: Charlotte Andersson; Gunnar H Gislason; Peter Weeke; Søren Hoffmann; Peter R Hansen; Christian Torp-Pedersen; Peter Søgaard Journal: Cardiovasc Diabetol Date: 2010-01-18 Impact factor: 9.951